Fundz

Francis Medical receives investment from JJDC to enhance its commercial infrastructure and support its FDA submission for prostate cancer treatment.

PRIVATENov 12, 2026

Round Type

Venture

Maple GroveHealthcareHealth Care

Investors

Johnson & Johnson Innovation – Jjdc, Inc.

Description

Francis Medical, a Maple Grove, MN-based provider of minimally invasive therapies for urological cancers, received an investment from Johnson & Johnson Innovation – JJDC, Inc (JJDC). The amount of the deal was not disclosed. The company intends to use the funds to scale its commercial infrastructure and strengthen physician training and education programs. They currently hold FDA 510(k) clearance for their Vanquish System as a thermal ablation tool.

Quick answer

Francis Medical raised an undisclosed amount in a funding round, dated November 12, 2026. Investors: Johnson & Johnson Innovation – Jjdc, Inc. Francis Medical is based in Maple Grove, Minnesota, United States.

How much did Francis Medical raise?
Francis Medical raised an undisclosed amount in a funding round on November 12, 2026.
Who invested in Francis Medical?
Johnson & Johnson Innovation – Jjdc, Inc. is named as investors in this round.
What does Francis Medical do?
Francis Medical is developing minimally invasive treatment solutions for prostate, kidney, and bladder cancer through the use of convective thermal water vapor.
Where is Francis Medical based and how big is it?
Francis Medical is based in Maple Grove, Minnesota, United States. Fundz records about 48 employees.
Who are the decision-makers at Francis Medical?
Fundz holds 1 contact at Francis Medical, including the Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Health Care around the same time

Companies in the same sectors as Francis Medical that raised within 45 days of this round, from Fundz verified event records.

  • XpertDox LLC raised $20M (Series A) on November 11, 2026.
  • Actuate Therapeutics raised $10M (Post-IPO Equity) on October 28, 2026.
  • Endovia Health Sciences, Inc. raised $135M (Post-IPO Equity) on October 27, 2026.
  • Recursion Pharmaceuticals raised $200M (Post-IPO Equity) on October 15, 2026.
  • Os Therapies raised $7.2M on October 15, 2026.
  • Ospitek raised an undisclosed amount on October 13, 2026.

Who to call at Francis Medical, and when

A new round usually means Francis Medical is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Francis Medical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Francis Medical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Francis Medical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Francis Medical

Location

7351 KIRKWOOD LANE N

Maple Grove, Minnesota, United States

About

Francis Medical is developing minimally invasive treatment solutions for prostate, kidney, and bladder cancer through the use of convective thermal water vapor. Currently, the company is in clinical trials for ablating cancerous prostate tissue.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Francis Medical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsMichael H., Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Francis Medical's next move

See what Strategic adds

Francis Medical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.